Blinded, controlled field trial of two commercially available mycoplasma bovis bacterin vaccines in veal calves

Vaccine

Volumn 29, Issue 33, 2011, Pages 5347-5354

  Soehnlen, Marty K ^a   Aydin, Adnan ^b   Lengerich, Eugene J ^a   Houser, Beth A ^a   Fenton, Ginger D ^a   Lysczek, Hannah R ^a   Burns, Carolyn M ^a   Byler, Louise I ^a   Hattel, Arthur L ^c   Wolfgang, David R ^a   Jayarao, Bhushan M ^a,c  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b Marcho Farms Inc   (United States)

^c Animal Diagnostic Laboratory   (United States)

Author keywords

Bacteria; Mycoplasma bovis; Respiratory infection; Veal calf

Indexed keywords

BACTERIAL VACCINE; BACTERIN; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MYCOMUNE; MYCOPLASMA BOVIS VACCINE; PLACEBO; PULMO GUARD; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BRONCHOPNEUMONIA; CALF (BOVINE); CATTLE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SAFETY; HISTOPATHOLOGY; INTERSTITIAL PNEUMONIA; MALE; MORBIDITY; MYCOPLASMA BOVIS; MYCOPLASMOSIS; NONHUMAN; OTITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; UPPER RESPIRATORY TRACT; VACCINATION; VEAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INJECTIONS, SUBCUTANEOUS; LUNG; MYCOPLASMA BOVIS; MYCOPLASMA INFECTIONS; RESPIRATORY TRACT DISEASES;

EID: 79960361641     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.05.092     Document Type: Article

References (34)

1. Arcangioli M., Duet A., Meyer G., Dernberg A., Bezille P., Pourmarat F., et al. The role of Mycoplasma bovis in bovine respiratory disease outbreaks in veal calf feedlots. Vet J 2008, 177:89-93.
2. Asokan G.V. Epidemiological assessment of vaccine efficacy. Vet World 2009, 2(3):118-122.
3. Beef Quality Assurance (BQA) Beef quality assurance national manual 2010, p. 4-15.
4. Bryson T., Ball H., Foster F., Brice N. Enhanced severity of induced Mycoplasma bovis pneumonia in calves following immunization with different antigenic extracts. Res Vet Sci 2002, A72(Suppl.):19.
5. Boothby J., Jasper D., Thomas C. Experimental intramammary inoculation with Mycoplasma bovis in vaccinated and unvaccinated cows: effect on local and systemic antibody response. Can J Vet Res 1987, 51:121-125.
6. Carroll E., Bennett R., Rollins M., Jasper D. The immune response of calves given Mycoplasma bovis antigens. Can J Comp Med 1977, 41:279-286.
7. Cartner S., Lindsey J., Gibbs-Erwin J., Cassell G., Simecka J. Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect Immun 1998, 66:3485-3491.
8. Cho Y.S., Lee H.S., Lim S., Joo Y.S., Kim J.M., Kim J.H. Safety and efficacy testing of a novel multivalent bovine bacterial respiratory vaccine composed of five bacterins and two immunogens. J Vet Med Sci 2008, 70(9):959-964.
9. Donovan G.A., Dohoo I., Montgomery D., Bennett F. Associations between passive immunity and morbidity and mortality in dairy heifers in Florida, USA. Prev Vet Med 1998, 34:31-46.
10. Finch J., Howard C. Inhibitory effect of Mycoplasma dispar and Mycoplasma bovis on bovine immune responses in vitro. Zentralbl Bakter 1990, 20(Suppl.):563-569.
11. Howard C., Gourlay R. Immune response of calves following inoculation of Mycoplasma dispar and Mycoplasma bovis. Vet Microbiol 1983, 8:45-56.
12. Howard C., Gourlay R., Taylor G. Immunity to Mycoplasma bovis infections of the respiratory tract of calves. Res Vet Sci 1980, 28:242-249.
13. Howard C., Stott E., Thomas L., Gourlay R., Taylor G. Protection against respiratory disease in calves induced by vaccines containing respiratory syncytial virus, parainfluenza type 3 virus, Mycoplasma bovis, and Mycoplasma dispar. Vet Rec 1987, 121(15):342-347.
14. Jungi T., Krampe M., Sileghem M., Griot C., Nicolet J. Differential and strain-specific triggering of bovine alveolar macrophage effector functions of mycoplasmas. Microb Pathogensis 1996, 21:487-498.
15. Le Grand D., Calavas D., Brank M., Citti C., Rosengarten R., Bezille P., et al. Serological prevalence of Mycoplasma bovis infection in suckling beef calves in France. Vet Rec 2002, 156:139-143.
16. Martin S.W. Vaccination: is it effective in preventing respiratory disease or influencing weight gains in feedlot calves. Can Vet J 1983, 24:10-19.
17. Maunsell F., Donovan G., Risco C., Brown M. Field evaluation of a Mycoplasma bovis bacterin in young diary calves. Vaccine 2009, 27:2781-2788.
18. Nicholas R., Baker S., Ayling R., Stipkovits L. Mycoplasma infections in growing cattle. Cattle Pract 2000, 8:115-118.
19. Nicholas R.A., Ayling R.D. Mycoplasma bovis: disease, diagnosis and control. Res Vet Sci 2003, 74:105-112.
20. Nicholas R.A., Ayling R.D., McAuliffe L. Mycoplasma diseases of ruminants 2008, CAB International, London, UK, 132-168.
21. Nicholas R.A., Ayling R.D., McAuliffe L. Vaccines for mycoplasma diseases in animals and man. J Comp Pathol 2009, 140:85-96.
22. Pfutzner H. Epizootiology of the Mycoplasma bovis infection of cattle. Zentralbl Bakter 1990, 20(Suppl.):394-399.
23. Razin S., Herrmann R. Molecular biology and pathogenicity of mycoplasmas 2002, Kluwer Academic/Plenum Publishers, New York, 445-464.
24. Rosengarten R., Citti C. The role of ruminant mycoplasmas in systemic infection. Mycoplasmas of ruminants: pathogenicity, diagnostics, epidemiology and molecular genetics 1999, vol. 3:14-31. European Commission, Brussels.
25. Saperstein S., Chen L., Oakes D., Pryhuber G., Finkelstein J. IL-1β augments TNF-α-mediated inflammatory responses from lung epithelial cells. J Interferon Cytokine Res 2009, 29:273-284.
26. Snowder G., Van Vleck L., Cundiff L., Bennett G. Bovine respiratory disease in feedlot cattle: Environmental, genetic, and economic factors. J Anim Sci 2006, 84:1999-2008.
27. Soehnlen MK. PhD Thesis. Pennsylvania State University, University Park, PA. Molecular characterization and epidemiology of Mycoplasma bovis; 2011. p 131-54.
28. Stipkovits L., Ripley P., Varga J., Palfi V. Clinical study of the disease of calves associated with Mycoplasma bovis infection. Acta Vet Hungary 2000, 48(4):387-395.
29. Stott E., Thomas L., Howard C., Gourlay R. Field trial of a quadrivalent vaccine against calf respiratory disease. Vet Rec 1987, 121(15):342-347.
30. Thomas A., Dizier I., Linden A., Mainil J., Frey J., Vilei E. Conservation of the uvrC gene sequence in Mycoplasma bovis and its use in routine PCR diagnosis. Vet J 2004, 168:100-102.
31. Urbaneck D., Liebig F., Forbig T., Stache B. Experiences with herd specific vaccines against respiratory infections with M. bovis in a large feedlot. Praktische Tierarzt 2000, 81(9):756-763.
32. Vanden Bush T., Rosenbusch R. Mycoplasma bovis induces apoptosis of bovine lymphocytes. FEMS Immunol Med Microbiol 2002, 32:97-103.
33. Vanden Bush T., Rosenbusch R. Characterization of the immune response to Mycoplasma bovis lung infection. Vet Immunol Immunopathol 2003, 94:23-33.
34. Wilson L., Egan C., Drake T. Blood, growth, and other characteristics of special-fed veal calves in private cooperator herds. J Dairy Sci 1994, 77:2477-2485.